Skip to Main Content

Paper Details

Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content.
Metabolites
7
2023
Bilirubin, Ceramide, Mice, NAFLD, Obese, bilirubin, ceramide, ceramides, diabetes, hepatic lipid accumulation, hyperbilirubinemia, metabolic diseases, mice, non-alcoholic fatty liver disease, obesity
Author NameAffiliation
Robert M FlightUniversity of Kentucky
Robert M FlightMarkey Cancer Center, University of Kentucky
Hunter N B MoseleyUniversity of Kentucky
Hunter N B MoseleyMarkey Cancer Center, University of Kentucky
Hunter N B MoseleyInstitute for Biomedical Informatics, University of Kentucky
Hunter N B MoseleyCenter for Clinical and Translational Sciences, University of Kentucky
  • 1 - 6

Datasets

Release 1.2